2.00
price up icon2.56%   0.05
after-market Dopo l'orario di chiusura: 2.00
loading

Medicinova Inc Borsa (MNOV) Ultime notizie

pulisher
Nov 19, 2024

MediciNova reports progress in ALS and Long COVID trials - Investing.com

Nov 19, 2024
pulisher
Nov 19, 2024

MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders - GlobeNewswire

Nov 19, 2024
pulisher
Nov 19, 2024

MediciNova Partners with NIH for ALS Trial, Reports $42.3M Cash Position | MNOV Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 17, 2024

StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV) - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

MediciNova Receives Notice of Allowance from United States - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova Secures Key Patent for Diabetes Treatment MN-001 Through 2042 | MNOV Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova stock hits 52-week high at $2.17 amid growth - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

MediciNova: Q3 Earnings Snapshot - New Haven Register

Nov 14, 2024
pulisher
Nov 13, 2024

3 US Penny Stocks With Market Caps Over $40M To Consider - Simply Wall St

Nov 13, 2024
pulisher
Nov 12, 2024

MediciNova stock hits 52-week high at $2.17 amid growth By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 11, 2024

MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

MediciNova Secures Major Settlement from Sanofi-Novartis Litigation, Boosts Clinical Pipeline | MNOV Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 11, 2024

Idiopathic Pulmonary Fibrosis Management Market Share and Size Report 2024-2031 - InsightAce Analytic

Nov 11, 2024
pulisher
Nov 07, 2024

MediciNova (NASDAQ:MNOV shareholders incur further losses as stock declines 11% this week, taking five-year losses to 80% - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

MediciNova (NASDAQ:MNOV) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

TSX Buyback Index (TXBB) QuotePress Release - The Globe and Mail

Nov 06, 2024
pulisher
Nov 04, 2024

Idiopathic Pulmonary Fibrosis Market Is Booming Worldwide - openPR

Nov 04, 2024
pulisher
Oct 30, 2024

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com - Defense World

Oct 30, 2024
pulisher
Oct 30, 2024

StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

MediciNova (NASDAQ:MNOV) Shares Cross Above Two Hundred Day Moving Average – Should You Sell? - Defense World

Oct 30, 2024
pulisher
Oct 30, 2024

MediciNova (NASDAQ:MNOV) Stock Price Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Oct 30, 2024
pulisher
Oct 25, 2024

Clean Harbors (CLH-N) QuotePress Release - The Globe and Mail

Oct 25, 2024
pulisher
Oct 23, 2024

MediciNova Announces Update of Phase 2/3 Clinical Trial of - GlobeNewswire

Oct 23, 2024
pulisher
Oct 23, 2024

MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium) - StockTitan

Oct 23, 2024
pulisher
Oct 22, 2024

MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com - MarketBeat

Oct 22, 2024
pulisher
Oct 22, 2024

MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com - Defense World

Oct 22, 2024
pulisher
Oct 17, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Oct 17, 2024
pulisher
Oct 16, 2024

MediciNova, Inc. (NASDAQ:MNOV) Shares Sold by Dimensional Fund Advisors LP - Defense World

Oct 16, 2024
pulisher
Oct 08, 2024

Type 1 Diabetes Market Report 2034: Epidemiology Data, Pipeline - openPR

Oct 08, 2024
pulisher
Oct 07, 2024

MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago - Yahoo Finance

Oct 07, 2024
pulisher
Oct 06, 2024

MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com - MarketBeat

Oct 06, 2024
pulisher
Sep 30, 2024

MNOV: MN-166 to be Evaluated in NIH-Sponsored Expanded Access Trial in ALS - Smartkarma

Sep 30, 2024
pulisher
Sep 30, 2024

MNOVMedicinova, Inc. Latest Stock News & Market Updates - StockTitan

Sep 30, 2024
pulisher
Sep 30, 2024

Short Interest in MediciNova, Inc. (NASDAQ:MNOV) Rises By 19.3% - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

MediciNova to Support NIH-Funded Expanded Access Clinical - GlobeNewswire

Sep 30, 2024
pulisher
Sep 30, 2024

MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS) - StockTitan

Sep 30, 2024
pulisher
Sep 28, 2024

MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average of $1.42 - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Amyotrophic Lateral Sclerosis Pipeline Insights, Treatment Drugs, Clinical Trials, and Companies 2024 - The Globe and Mail

Sep 27, 2024
pulisher
Sep 25, 2024

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Stockhouse Publishing

Sep 25, 2024
pulisher
Sep 25, 2024

Insigneo Advisory Services LLC Has $6.10 Million Stock Position in Mastercard Incorporated (NYSE:MA) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Intech Investment Management LLC Takes Position in MSA Safety Incorporated (NYSE:MSA) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Minerals Technologies (NYSE:MTX) Upgraded at StockNews.com - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Monroe Capital (NASDAQ:MRCC) Stock Crosses Above 200 Day Moving Average of $7.49 - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

MARXU stock soars to all-time high of $12.15 amid market optimism - Investing.com Australia

Sep 25, 2024
pulisher
Sep 24, 2024

Marcus (NYSE:MCS) Upgraded by StockNews.com to Hold - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Mistras Group senior EVP sells over $349k in company stock - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX) - Stockhouse Publishing

Sep 24, 2024
pulisher
Sep 24, 2024

Summit Trail Advisors LLC Buys 403 Shares of Moderna, Inc. (NASDAQ:MRNA) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

MacroGenics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMGNX - Longview News-Journal

Sep 24, 2024
pulisher
Sep 23, 2024

MasterBrand (NYSE:MBC) Hits New 52-Week High at $19.10 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

ProShare Advisors LLC Sells 43,073 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Mutual of America Capital Management LLC Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Mutual of America Capital Management LLC Decreases Stake in MSA Safety Incorporated (NYSE:MSA) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

2024-09-23 | Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class ActionContact The Gross Law Firm to Learn More | NDAQ:MGNX | Press Release - Stockhouse Publishing

Sep 23, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Capitalizzazione:     |  Volume (24 ore):